Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Pregabalin

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Lyrica

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    May 2026 Price Concessions: Third Update
    May 2026 Price Concessions: Third Update

    22 May 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7470808

    FIRSTWORD PHARMA
    22 May 2026
    Share Share
    Centre Moves Pregabalin To Schedule H1 To Combat Drug Misuse
    Centre Moves Pregabalin To Schedule H1 To Combat Drug Misuse

    22 May 2026

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pregabalin-moved-to-schedule-h1-as-centre-cracks-down-on-drug-misuse/articleshow/131258316.cms

    ECONOMICTIMES
    22 May 2026
    Share Share
    Liavium-CA1 Pregabalin Gets FDA Conditional OK for Canine Pain
    Liavium-CA1 Pregabalin Gets FDA Conditional OK for Canine Pain

    18 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/liavium-ca1-pregabalin-chewable-tablets-receives-fda-conditional-approval-redefining-canine-neuropathic-pain-care-302773962.html

    PR NEWSWIRE
    18 May 2026
    Share Share
    Fourrts’ Generics Pregabalin Receives Approval in US
    Fourrts’ Generics Pregabalin Receives Approval in US

    24 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218529

    FDA
    24 Feb 2026
    Share Share
    Health Ministry Proposes Pregabalin For Schedule H1 Inclusion
    Health Ministry Proposes Pregabalin For Schedule H1 Inclusion

    31 Jan 2026

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=183878&sid=1

    PHARMABIZ
    31 Jan 2026
    Share Share
    Drug Misuse: Govt May Curb 'Pregabalin' Sales
    Drug Misuse: Govt May Curb 'Pregabalin' Sales

    29 Jan 2026

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/drug-misuse-govt-may-curb-pregabalin-sales/articleshow/127730254.cms

    ECONOMICTIMES
    29 Jan 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.